CSL to the rescue
“Coronavirus is quite different to influenza virus so is not a core area of focus for CSL. On saying that, given the mounting public health issue this has become, we are investigating what adjacencies in expertise, technologies and facilities we might contribute as a collaborator to the global effort."
In the meantime, brace yourselves for the coronavirus-related biotech bubble. It feels a bit like the dot.com bubble of 2000. When that burst there were only a few winners but plenty of investors nursing financial burns.
Coronavirus, page-34
-
- There are more pages in this discussion • 107 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$308.56 |
Change
1.960(0.64%) |
Mkt cap ! $149.1B | |||
| Open | High | Low | Value | Volume |
| $308.93 | $311.00 | $306.28 | $198.7M | 643.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 859 | $308.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $308.65 | 5 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| CSL (ASX) Chart |